Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - Relevance of asian population studies

Review of Diabetic Studies

Volumn 6, Issue 4, 2009, Pages 237-246

  Wang, Pei Wen ^a   Lin, Tsu Kung ^a   Weng, Shao Wen ^a   Liou, Chia Wei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Biosynthesis; Mitochondrial DNA; Phenotype; Reactive oxygen species; Type 2 diabetes

Indexed keywords

INSULIN; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

AFRICA; ASIAN; BIOGENESIS; BRAIN INFARCTION; CELL DEATH; CELL FUNCTION; CELL ORGANELLE; CELL SURVIVAL; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY RESOURCE; EUROPEAN AMERICAN; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC SYNDROME X; MITOCHONDRION; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PHYLOGENY; POPULATION RESEARCH; RACE DIFFERENCE; REVIEW;

EID: 75749107843     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.237     Document Type: Review

References (108)

1. Alcolado JC, Alcolade R. Importance of material history of non-insulin dependent diabetic patients. BMJ 1991. 302 (6786):1178-1180.
2. Lin RS, Lee WC, Lee YT, Chou P, Fu CC. Material role in type 2 diabetes mellitus: indirect evidence for a mitochondrial inheritance. Int J Epidemiol 1994. 23(5):886-890.
3. Van den Quweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, deVijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA. Mutation in mitochondrial tRNA (leu) (UUR) gene in a large pedigree with maternally transmitted type 2 diabetes mellitus and deafness. Nat Genet 1992. 1(5):368-371.
4. Tawata M, Hayashi JI, Isobe K, Ohkuno E, Ohtaka M, Chen J, Aida K, Onaya T. A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes 2000. 49(7):1269-1272.
5. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992. 340 (8832):1376-1379.
6. Liou CW, Huang CC, Wei YH. Molecular analysis of diabetes mellitus-associated A3243G mitochondrial DNA mutation in Taiwanese cases. Diab Res Clin Pract 2001. 54(Suppl 2):S39.
7. Ballinger SW. Maternally transmitted diabetes and deafness associated with a 10.4 Kb mitochondrial DNA deletion. Nat Genet 1992. 1(1):11-15.
8. Rotig A. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am J Hum Genet 1992. 50 (2):364-370.
9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001. 414 (6865):813-820.
10. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCOMCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001. 17(3):189-212.
11. Ceriello A, Ihnat MA, Thorpe JE. The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009. 94(2):410-415.
12. Peterson KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulinresistant offspring of patients with type 2 diabetes. N Engl J Med 2004. 350(7):664-671.
13. Grossman LI, Watson R, Vinograd J. The presence of ribonucleotides in mature closed-circular mitochondrial DNA. Proc Natl Acad Sci USA 1973. 70(12):3369-3343.
14. Arnberg A, van Bruggen EF, Borst P. The presence of DNA molecules with a displacement loop in standard mitochondrial DNA preparations. Biochim Biophys Acta 1971. 246(2):353-357.
15. Yasukawa T, Yang MY, Jacobs H, Holt IJ. A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA. Mol Cell 2005. 18(6):651-662.
16. Greenberg BD, Newbold IE, Sugino A. Intraspecific nucleotide sequence variability surrounding the origin of replication in human mitochondrial DNA. Gene 1983. 21(1-2):33-49.
17. Lutz S, Weisser HJ, Heizmann J, Pollak S. A third hypervariable region in the human mitochondrial D-loop. Hum Gene 1997. 101(3):384.
18. Wallace D, Brown M, Lott M. Mitochondrial DNA variation in human evolution and disease. Gene 1999. 238(1):211-230.
19. Castro JA, Picornell A, Ramon M. Mitochondrial DNA: a tool for populational genetics studies. Int J Legal Med 1998. 1(4):327-332.
20. Ballinger SW, Schurr TG, Torroni A, Gan YY, Hodge JA, Hassan K, Chen KH, Wallace DC. Southern Asian mitochondrial DNA analysis reveals genetic continuity of ancient mongoloid migrations. Genetics 1992. 130(1):139-152.
21. Coskun PE, Ruiz-Pesini E, Wallace DC. Control region mtDNA variants: Longevity, climatic adaptation, and a forensic conundrum. Proc Natl Acad Sci USA 2003. 100(5):2174-2176.
22. Yakes FM, van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997. 94(2):514-519.
23. Croteau DL, Stierum RH, Bohr VA. Mitochondrial DNA repair pathways. Mutat Res 1999. 434(3):137-148.
24. Attardi G, Schatz G. Biogenesis of mitochondria. Annu Rev Cell Biol 1988. 4:289-333.
25. Lee HC, Wei YH. Mitochondrial role in life and death of the cell. J Biomed Sci 2000. 7(1):2-15.
26. Lee HC, Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell 2005. 37(4):822-834.
27. Fernandez-Silva P, Enriquez A, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 2003. 88(1):41-56.
28. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 2002. 1576(1-2):1-14.
29. Gleyzer N, Vercauteren K, Scarpulla RC. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol 2005. 25(4):1354-1366.
30. Doleris LM, Hill GS, Chedin P, Nochy D, Bellanne-Chantelot C, Hanslik T, Bedrossian J, Caillat-Zucman S, Cahen-Varsaux J, Bariety J. Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 2000. 58(5):1851-1858.
31. Hagiwara M, Yamagata K, Capaldi RA, Koyama A. Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis. Kidney Int 2006. 69(7):1146-1152.
32. Ortiz A, Justo P, Catalan MP, Sanz AB, Lorz C, Egido J. Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2002. 2(2):181-192.
33. Takebayashi S, Kaneda K. Mitochondrial derangement: possible initiator of microalbuminuria in NIDDM. J Diabt Complications 1991. 5(2-3):104-106.
34. Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004. 27(8):2057-2066.
35. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003. 37(5):1202-1219.
36. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002. 60(9):289-293.
37. de la Torre JC. Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis 2008. 5(3-4):126-132.
38. Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res 2003. 5(7):491-504.
39. Dodson MW, Guo M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 2007. 17(3):331-337.
40. Wei YH, Lu CY, Lee HC Pang CY, Ma YS. Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci 1998. 854:155-170.
41. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003. 552(Pt2):335-344.
42. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988. 85(17):6465-6467.
43. Limon-Pacheco J, Gonsebatt ME. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 2009. 674(1-2):137-147.
44. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002. 82(1):47-95.
45. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005. 38(10):1278-1295.
46. Lee HC, Yin PH, Lu CY, Chi CW, Wei YH. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochemical Journal 2000. 348(Pt2):425-432.
47. Gogvadze V, Orrenius S. Mitochondrial regulation of apoptotic cell death. Chem Biol Interact 2006. 163(1-2):4-14.
48. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998. 281(5381):1309-1312.
49. Gronski MA, Weinem M. Death pathways in T cell homeostasis and their role in autoimmune diabetes. Rev Diabet Stud 2006. 3(2):88-95.
50. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987. 30(10):763-768.
51. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, Kesaniemi YA. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992. 35(11):1060-1067.
52. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 1999. 42(2):146-150.
53. Neel JV. Diabetes Mellitus: a "thrifty" genotype rendered detrimental by "Progress"? Am J Hum Genet 1962. 14:353-362.
54. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978. 108(6):497-505.
55. Hanson RL, Elston RC, Pettitt DJ, Bennett PH, Knowler WC. Segregation analysis of non-insulin dependent diabetes mellitus in Pima Indians: evidence for a majorgene effect. Am J Hum Genet 1995. 57(1):160-170.
56. King H, Rewers N. Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group. Bull World Health Organ 1991. 69(6):643-648.
57. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992. 35(7):595-601.
58. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989. 2(8663):577-580.
59. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991. 303(6809):1019-1022.
60. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993. 36(1):62-67.
61. Rich Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, Hennekens CH. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 1997. 315(7105):396-400.
62. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to noninsulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996. 312(7028):406-410.
63. Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L, Lithell UB, McKeigue PM. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15000 Swedish men and women born 1915-1929. BMJ 1998. 317(7153):241-245.
64. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitaudinal study. BMJ 1999. 318(7181):427-431.
65. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, Bleker OP. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998. 351(9097):173-177.
66. Poulton J. Does a common mitochondrial DNA polymorphism underlie susceptibility to diabetes and the thrifty genotype? Trend Genet 1998. 14(10):387-389.
67. Anderson S, Bankier AT, Barrell BG de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG. Sequence and organization of the human mitochondrial genome. Nature 1981. 290(5806):457-465.
68. Massen JA, van Essen E, van den Quweland JM, Lemkes HH. Molecular and clinical aspects of mitochondrial diabetes mellitus. Exp Clin Endocrinol Diabetes 2001. 109(3):127-134.
69. Frederiksen AL, Jeppesen TD, Vissing J, Schwartz M, Kyvik KO, Schmitz O, Poulsen PL, Anderson PH. High prevalence of impaired glucose homeostasis and myopathy in asymptomatic and oligosymptomatic 3243A>G mitochondrial DNA mutation-positive subjects. J Clin Endocrinol Metab 2009.94(8):2872-2879.
70. Gerbitz KD, van den Quweland MW, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1995. 1271(1):253-260.
71. Song J, Yound J, Sung YA, Pak YK, Park KS, Lee HK. Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients. Diabetes Care 2001. 24(5):865-869.
72. Lee HK, Song JH, Shin CS, Park DJ, Park KS, Lee KU, Koh CS. Peripheral blood mitochondrial DNA content can predict the development of diabetes. Diabetes 1997. 46(Suppl 1):175A.
73. Park KS, Lee KU, Song JH, Choi CS, Shin CS, Park DJ, Kim SK, Koh JJ, Lee HK. Peripheral blood mitochondrial DKA content is inversely correlated with insulin secretion during hyperglycemic clamp studies in healthy young men. Diabetes Res Clin Pr 2001. 52(2):97-102.
74. Weng SW, Lin TK, Liou CW, Chen SD, Wei YH, Lee HC, Chen IY, Hsieh CJ, Wang PW. Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism Diabetes Res Clin Pr 2009. 83(1):94-99.
75. Singh R, Hattersley AT, Harries LW. Reduced peripheral blood mitochondrial DNA content is not a risk factor for type 2 diabetes. Diabetic Med 2007. 24(7):784-787.
76. Shen X, Zheng S, Thongboonkerd V, Xu M, Pierce WM Jr, Klein JB, Epstein PN. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab 2004. 287(5):E896-E905.
77. Wang PW. Tissue-specific difference of mitochondrial DNA content in type 2 diabetes. The 10th symposium on molecular diabetology in Asia and The 1st Sun Yat-Sen diabetes forum, Guangzhou, China, Nov 28-30, 2008.
78. Morten KJ, Poulton J, Sykes B. Multiple independent occurrence of the 3243 mutations in mitochondrial tRNA leuUUR in patients with the MELAS phenotype. Hum Mol Genet 1995. 4(9):1689-1691.
79. Casteels K, Ong K, Phillips D, Bendall H, Pembrey M. Mitochondrial 16189 variant, thinness at birth, and type 2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood.. Lancet 1999. 353(9163):1499-1500.
80. Poulton J, Brown MS, Cooper A, Marchington DR, Philips DI. A common mitochondrial DNA variant is associated with insulin resistance in adult life. Diabetologia 1998. 41(1):54-58.
81. Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ. Type 2 diabetes is associated with a common mitochondrial variant: evidence from a populationbased case-control study. Hum Mol Genet 2002. 11(13):1581-1583.
82. Liou CW, Lin TK, Huang FM, Chen TL, Lee CF, Chuang YC, Tan TY, Chang KC, Wei YH. Association of the mitochondrial DNA 16189 T to C variant with lacunar cerebral infarction: evidence from a hospital-based case-control study. Ann N Y Acad Sci 2004. 1011:317-324.
83. Weng SW, Liou CW, Lin TK, Wei YH, Lee CF, Eng HL, Chen SD, Liu RT, Chen JF, Chen IY, Chen MH, Wang PW. Association of mitochondrial DNA 16189 variant (T->C transition) with metabolic syndrome in Chinese adults. J Clin Endocr Metab 2005. 90(9):5037-5040.
84. Liou CW, Lin TK, Weng HH, Lee CF, Chen TL, Wei YH, Chen SD, Chuang YC, Weng SW, Wang PW. A common mtDNA variant and increased body mass index as associated factors for development of type 2 diabetes: Additive effects of genetic and environmental factors. J Clin Endocrinol Metab 2007. 92(1):235-239.
85. Saxena R, Bakker PIW, Singer K, Mootha V, Burtt N, Hirschhorn JN, Gaudet D, Isomaa B, Daly MJ, Groop L, Ardlie KG, Altshuler D. Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet 2006. 79(1):54-61.
86. Mohlke KL, Jackson AU, Scott LJ, Peck EC, Suh YD, Chines PS, Watanabe RM, Buchanan TA, Conneely KN, Erdos MR, et al. Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum Genet 2005. 118(2):245-254.
87. Chinnery PF, Elliott HR, Patel S, Lambert C, Keers SM, Durham SE, McCarthy MI, Hitman GA, Hattersley AT, Walker M. Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet 2005. 366(9497):1650-1651.
88. Das S, Bennettn AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Franks S, Elliott P, Poulton J, Jarvein MR, McCarthy MI. Detailed analysis of variation at and around mitochondrial position 16189 in a large finnish cohort reveals no significant association with early growth or metabolic phenotypes at age 31 years. J Clin Endocrinol Metab 2007. 92(8):3219-3223.
89. Park KS, Chan JC, Chuang LM, Sukui S, Araki E, Nanjo K, Ji L, Ng M, Nishi M, Furuta H, et al. A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia 2008. 51:602-608.
90. Kim JH, Park KS, Cho YM, Kang BS, Kim SK, Jeon HJ, Kim SY, Lee HK. The prevalence of the mitochondrial DNA 16189 variant in non-diabetic Korean adults and its association with higher fasting glucose and body mass index. Diabet Med 2002. 19(8):681-684.
91. Horai S, Hayasaka K. Intraspecific nucleotide sequence differences in the major noncoding region of human mitochondrial DNA. Am J Hum Genet 1990. 46(4):828-842.
92. Ji L, Gao L, Han X. Association of 16189 variant (T-->C transition) of mitochondrial DNA with genetic predisposition to type 2 diabetes in Chinese populations. Zhonghua Yi Xue Za Zhi 2001. 81(12):711-714.
93. Tang DL, Zhou X, Li X, Zhao L, Liu F. Variation of mitochondrial gene and the association with type 2 diabetes mellitus in a Chinese population. Diabetes Res Clin Pract 2006. 73(1):77-82.
94. Malik S, Sudoyo H, Pramoonjago P, Sukarna T, Darwis D, Marzuki S. Evidence for the de novo regeneration of the pattern of the length heteroplasmy associated with the T16189C variant in the control (D-loop) region of mitochondrial DNA. J Human Genet 2002. 47(3):122-130.
95. Malik S, Sudoyo H, Pramoonjago P, Suryadi H, Sukarna T, Nyunting M, Sahiratmadja E, Martuki S. Nuclear mitochondrial interplay in the modulation of the homopolymeric tract length heteroplasmy in the control (Dloop) region of the mitochondrial DNA. Hum Genet 2002. 110(5):402-411.
96. Batista O, Kolman CJ, Bermingham E. Mitochondrial DNA diversity in the Kuna Amerinds of Panama. Hum Mol Genet 1995. 4(5):921-929.
97. Mountain JL, Hebert JM, Bhattacharyya S, Underhill PA, Ottolenghi C, Gadgil M, Cavalli-Sforza LL. Demographic history of India and mtDNA-sequence diversity. Am J Hum Genet 1995. 56(4):979-992.
98. Templeton A. Out of Africa again and again. Nature 2002. 416(6876):45-51.
99. Hung YT, Wang PW, Hsieh CJ, Weng SW, Lin TK, Tiao MM, Chen JB, Liou CW. Sequence polymorphism of mitochondrial D-loop DNA in the southern Taiwanese. 2008 Conference of Taiwan Society for Mitochondrial Research and Medicine, Keelung, Taiwan, Feb 16-17, 2008.
100. Marchington DR, Poulton J, Sellar A, Holt IJ. Do sequence variations is in the major non-coding region of mitochondrial genome influence mitochondrial mutations asso ciated with disease? Hum Mol Genet 1996. 5(4):473-479.
101. Gill-Randall R, Sherratt EJ, Thomas AW, Gagg JW, Lee A, Alcolado JC. Analysis of a polycytosine tract and heteroplasmic length variation in the mitochondrial DNA D-loop of patients with diabetes, MELAS syndrome and race-matched controls. Diabet Med 2001. 18(5):413-416.
102. Lin TK, Chen SD, Wang PW, Wei YH, Lee CF, Chen TL, Chuang YC, Tan TY, Chang KC, Liou CW. Increased oxidative damage with altered antioxidative status in type 2 diabetic patients harboring the 16189 T to C variant of mitochondrial DNA. Ann N Y Acad Sci 2005.1042:64-69.
103. Tanaka M, Fuku N, Nishigaki Y, Matsuo H, Segawa T, Watanabe S, Kato K, Yokoi K, Ito M, Nozawa Y, Yamada Y. Women with mitochondrial haplogroup N9a are protected against metabolic syndrome. Diabetes 2007. 56(2):518-521.
104. Fuku N, Park KS, Yamada Y, Nishigaki Y, Cho YM, Matsuo H, Segawa T, Watanabe S, Kato K, Yokoi K, Nozawa Y, Lee HK, Tanaka M. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet 2007. 80(3):407-415.
105. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes for BioMedical Research, Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007. 316(5829):1331-1336.
106. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007. 316(5829):1336-1341.
107. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007. 316(5829):1341-1345.
108. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D'Agostino RB Sr, Cupples LA. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008. 359(21):2208-2219.